The invention discloses a synbiotic compound preparation conducive to alleviation of hypertension symptoms without solid lesions. A formula of the synbiotic compound preparation comprises 8%-12% of bifidobacterium infantis, 8%-12% of bifidobacterium longum, 8%-12% of bifidobacterium breve, 3%-6% of lactobacillus acidophilus, 3%-6% of lactobacillus casei, 3%-6% of lactobacillus rhamnosus, 3%-6% oflactobacillus plantarum, 3%-6% of lactobacillus paracasei, 3%-6% of lactobacillus bulgaricus, 12%-18% of streptococcus thermophilus, 0.2%-0.8% of sodium acetate, 0.4-0.8% of sodium butyrate, 1.2%-1.5%of fructo-oligosaccharide, 0.5%-0.9% of lactulose, 0.1%-0.5% of barley malt powder, 1.4%-1.8% of skim sheep milk powder, 1.3%-1.8% of active hexose correlated compound, 0.8%-1.4% of inulin and 0.2%-0.5% of plantago ovate shell. The invention further discloses a preparation method of the synbiotic compound preparation conducive to alleviation of hypertension symptoms without solid lesions. The preparation method includes steps of quantitative weighing, probiotic culture, probiotic fermentation, skim sheep milk resuspension and mixing for capsule preparation.

48 results about "Plantago erosa" patented technology

Popular searches